J&J To Buy Intra-Cellular, Psychiatric Drug Caplyta For $14.6bn

Deal May Launch Anticipated Year Of Larger M&A

 
• By Joseph Haas
  
J&J flag
Johnson & Johnson inks $14.6bn proposed buyout of Intra-Cellular • Source: Alamy

More from Deals

More from Therapy Areas